Edwards Lifesciences (EW) Inventory Average (2016 - 2025)
Edwards Lifesciences has reported Inventory Average over the past 16 years, most recently at $1.1 billion for Q4 2025.
- Quarterly results put Inventory Average at $1.1 billion for Q4 2025, up 3.48% from a year ago — trailing twelve months through Dec 2025 was $1.1 billion (up 3.48% YoY), and the annual figure for FY2025 was $1.1 billion, up 11.19%.
- Inventory Average for Q4 2025 was $1.1 billion at Edwards Lifesciences, down from $1.1 billion in the prior quarter.
- Over the last five years, Inventory Average for EW hit a ceiling of $1.1 billion in Q3 2025 and a floor of $728.6 million in Q1 2022.
- Median Inventory Average over the past 5 years was $957.6 million (2023), compared with a mean of $935.5 million.
- Biggest five-year swings in Inventory Average: dropped 7.19% in 2022 and later surged 34.37% in 2023.
- Edwards Lifesciences' Inventory Average stood at $732.2 million in 2021, then rose by 11.53% to $816.6 million in 2022, then grew by 18.53% to $968.0 million in 2023, then rose by 13.17% to $1.1 billion in 2024, then grew by 3.48% to $1.1 billion in 2025.
- The last three reported values for Inventory Average were $1.1 billion (Q4 2025), $1.1 billion (Q3 2025), and $1.1 billion (Q2 2025) per Business Quant data.